Loading clinical trials...
Loading clinical trials...
This study aims to evaluate the effect of a novel hemodynamic management and monitoring strategy for reducing cardiac bio marker elevations and major adverse cardiac events.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vanderbilt University Medical Center
Collaborators
NCT07258875 · Thoracic Surgery With One-lung Ventilation, VExUS, and more
NCT07136532 · Septic Shock, Echocardiography Guided Fluid Management
NCT06486636 · Atrial Fibrillation, Atrial Flutter, and more
NCT06406998 · Cardiovascular Diseases, Atherosclerosis, and more
NCT05443321 · Infections, Heart Failure, and more
Vanderbilt University Medical Center
Nashville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions